News

Affirm's Impressive Growth and New Partnership with Amazon

Affirm's Impressive Growth and New Partnership with Amazon

A Bright Future for Affirm Holdings, Inc.

Affirm Holdings, Inc. (NASDAQ: AFRM) has recently experienced a significant surge in its shares following the release of impressive fiscal first-quarter results. The firm managed to exceed analyst expectations, igniting renewed interest in its buy-now, pay-later services. Investors are keen to see how this performance can shape the company's trajectory going forward.

Remarkable Fiscal Performance

Affirm's results for the first quarter were nothing short of remarkable. The company reported earnings of 23 cents per share, far surpassing the consensus estimate of just 11 cents. The revenue reached an impressive $933.33 million, comfortably exceeding the expected $883.14 million and representing an increase from $698.47 million from the previous year. These figures highlight Affirm's ability to grow its business, even in a competitive market.

CEO's Insights

Max Levchin, the CEO of Affirm, was quick to attribute this success to the company’s operational strength and consistent execution. He stated, "Results like these are never an accidental success. The last several quarters have felt like a steady acceleration of our strengths." A noteworthy achievement during this quarter is the highest-ever gross merchandise value (GMV), achieved despite fewer shopping holidays compared to previous quarters.

Analyst Optimism Surrounding Affirm

Prior to the earnings release, JPMorgan analyst Reginald L. Smith reaffirmed an Overweight rating on Affirm with a price target set at $94. His forecast suggested another GMV and revenue beat was on the horizon, which has since been validated with the latest results. This optimism among analysts reflects a positive outlook for Affirm's continued growth.

Market Reactions

Following the earnings announcement, BofA Securities analyst Jason Kupferberg maintained a Buy rating while increasing his price target from $94 to $98. Conversely, Morgan Stanley's James Faucette opted to keep his Equal-Weight rating but adjusted his target down from $90 to $83. These diverging opinions on valuation indicators reveal the market's varied reactions to Affirm's recent surge in performance.

Expanding Partnerships

In addition to its impressive financial results, Affirm has announced an expanded partnership with Amazon. This new five-year agreement, effective February 1, 2026, aims to extend Affirm's installment loan offerings to eligible Amazon shoppers through Amazon Pay, including certain third-party retailer sites. This aligns with Affirm's broader strategy to enhance its service offerings and provide customers with flexible payment options.

Price Action of AFRM

At the last check, shares of AFRM traded 9.15% higher at $71.90, reflecting the positive sentiment following the earnings report and the news of the partnership with Amazon. Investors appear to be confident in Affirm’s growth trajectory and its ability to capture more market share in the evolving financial services industry.

Frequently Asked Questions

What are Affirm's recent financial results?

Affirm reported earnings of 23 cents per share and revenue of $933.33 million, both exceeding analyst expectations.

Who is the CEO of Affirm Holdings?

Max Levchin serves as the CEO of Affirm Holdings, Inc.

What is Affirm's relationship with Amazon?

Affirm has entered into a five-year agreement with Amazon to extend its installment loan offerings to Amazon shoppers.

How have analysts reacted to Affirm's recent performance?

Analysts are optimistic, with price targets being raised, reflecting confidence in Affirm’s growth potential.

What is the stock performance of AFRM?

Shares of AFRM rose by 9.15% to $71.90 following positive earnings results and news of the Amazon partnership.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 115

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 163

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 104

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 98

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 89

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

SPHEREboard 6.11 Launch Enhances Identity Security Solutions

Updated Category News Views 153

SPHEREboard 6.11 Launch Elevates Identity Intelligence SPHERE, a frontrunner in Identity Intelligence, has recently accomplished two major milestones that are set to reshape identity security: the launch of SPHEREboard 6.11 and the formation of a dedicated Board of Advisors. These initiatives reflect SPHERE's unwavering commitment to not only enhancing identity hygiene...

Continue Reading
Edible Garden Expands Organic Herb Offerings in New Jersey

Updated Category News Views 127

Edible Garden Launches Organic Herb Line in Local Supermarkets Exciting news for herb enthusiasts! Edible Garden AG Incorporated, a leader in controlled environment agriculture, has announced the launch of its USDA Organic herb product line at select supermarkets in New Jersey. These include Superfresh, City Supermarket, and Fine Fare Supermarkets. Distinct Offerings from...

Continue Reading
Strengthening Cybersecurity: The Evolving Role of CISOs

Updated Category News Views 48

Cybersecurity in Today's Business Landscape As organizations navigate through the constantly changing threat landscape, cybersecurity has emerged as a crucial element of strategic business frameworks. Companies are increasingly recognizing the significance of enhancing their security postures, prioritizing the role of Chief Information Security Officers (CISOs), and...

Continue Reading
Qnity Takes Major Steps With Form 10 Registration Announcement

Updated Category News Views 232

Qnity Celebrates Effective Form 10 Registration Statement In a recent development that emphasizes growth, Qnity is thrilled to announce the effectiveness of its Form 10 registration statement. This milestone is crucial for Qnity as it advances its strategies while aligning with DuPont de Nemours, Inc. (NYSE: DD). The registration is a significant step towards enhancing...

Continue Reading
Important Position Disclosure by Rathbones Group Plc

Updated Category News Views 119

Overview of the Disclosure Process Understanding the dynamics of stock market dealings is crucial for every investor. Rathbones Group Plc plays a significant role in this context, especially when it comes to complying with regulatory frameworks. One such requirement is the public disclosure related to significant ownership positions in relevant securities, particularly...

Continue Reading